Morgan Stanley’s IceCure Medical ICCM Stock Holding History
Bought
Maintained
Sold
Other funds holding ICCM
SRL
HF
GCM
KFG
SS
BCWM
Morgan Stanley's ICCM Position: Q2 2026 in Review
Morgan Stanley increased its IceCure Medical (ICCM) stake by 664% in Q2 2026, buying an estimated $27.2K and bringing the position to 4,334 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6796.
Morgan Stanley first reported a position in ICCM in Q4 2021 and has held it in 12 quarters since. 11 funds tracked by Wall St. Rank hold ICCM as of Q2 2026.
- Morgan Stanley held 4,334 shares of IceCure Medical worth $21.1K as of Q2 2026.
- Morgan Stanley bought 3,767 IceCure Medical shares in Q2 2026, an estimated $27.2K.
- IceCure Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6796 holding.
- Morgan Stanley first reported a position in IceCure Medical in Q4 2021 and has held it in 12 quarters since.
- 11 funds tracked by Wall St. Rank held IceCure Medical as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.